Benzinga | Dec 11, 2020 05:11AM EST

SVB Leerink Maintains Outperform on Edwards Lifesciences, Raises Price Target to $106

SVB Leerink analyst Danielle Antalffy maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $100 to $106.